Protection against tetanus toxin in mice nasally immunized with recombinant Lactococcus lactis expressing tetanus toxin fragment C

By Norton P.M.   Wells J.M.   Brown H.W.G.   Macpherson A.M.   Le Page R.W.F.  

Vaccine, Vol. 15, Iss. 6, 1997-04 ,pp. : 616-619

Elsevier

Access to resources Recommend Favorite

A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC)

By Stratford R.   Douce G.   Bowe F.   Dougan G.  

Vaccine, Vol. 20, Iss. 3, 2001-11 ,pp. : 516-525

Elsevier

Access to resources Recommend Favorite

Intranasal or subcutaneous co-administration of recombinant cholera toxin B subunit stimulates only a slight or no level of the specific IgE response in mice to tetanus toxoid

By Isaka M.   Yasuda Y.   Kozuka S.   Taniguchi T.   Miura Y.   Matano K.   Goto N.   Tochikubo K.  

Vaccine, Vol. 17, Iss. 7, 1999-02 ,pp. : 944-948

Elsevier

Access to resources Recommend Favorite

Comparison of the immune responses induced by local immunizations with recombinant Lactobacillus plantarum producing tetanus toxin fragment C in different cellular locations

By Reveneau N.   Geoffroy M.-C.   Locht C.   Chagnaud P.   Mercenier A.  

Vaccine, Vol. 20, Iss. 13, 2002-03 ,pp. : 1769-1777

Elsevier

Access to resources Recommend Favorite

Intranasal murine model of Bordetella pertussis infection: II. Sequence variation and protection induced by a tricomponent acellular vaccine

By Boursaux-Eude C.   Thiberge S.   Carletti G.   Guiso N.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2651-2660

Elsevier

Access to resources Recommend Favorite